Description

Clindamycin 3-Palmitate is a lipophilic ester derivative of the lincosamide antibiotic clindamycin. This chemical modification enhances its stability and alters its pharmacokinetic profile, making it a valuable intermediate in advanced pharmaceutical synthesis. It is primarily utilized by manufacturers in the pharmaceutical industry for the research and development of specialized antibiotic formulations. The compound is supplied to meet the stringent quality requirements of GMP-compliant production environments.

Application

• Pharmaceutical Intermediate: Key starting material for the synthesis of specialized clindamycin prodrugs and derivatives.
• Antibiotic Formulation R&D: Used in research to develop novel topical or oral antibiotic products with modified release characteristics.
• Veterinary Medicine: Potential application in the development of long-acting antibiotic treatments for animal health.
• Chemical Reference Standard: Serves as a high-purity standard for analytical testing and quality control in pharmaceutical laboratories.
• Prodrug Synthesis: Utilized in creating prodrugs designed to improve the bioavailability or targeting of clindamycin.
• Microbiological Research: Employed in studies investigating the structure-activity relationships of lincosamide antibiotics.

Basic Information

Product Name	Clindamycin 3-Palmitate
CAS No.	68225-59-2
Molecular Formula	C34H63ClN2O6S
Molecular Weight	663.40 g/mol
Synonyms	Clindamycin Palmitate; Clindamycin 3-Hexadecanoate; 7(S)-Chloro-7-deoxylincomycin 3-palmitate; Dalacin® P (trade name precursor); U-28508; Clindamycin ester with palmitic acid; Methyl 7-chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-L-threo-α-D-galacto-octopyranoside 3-palmitate
EINECS	Contact for details

Quality Control

Our Clindamycin 3-Palmitate is manufactured under strict quality management systems. Each batch is tested to ensure it meets high-purity standards suitable for pharmaceutical research and development. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with every shipment. We can supply material that aligns with relevant pharmacopeial monographs for clindamycin derivatives upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to prevent moisture absorption.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.